Dizal (Jiangsu) Pharmaceutical Co (SHSE:688192) Future 3-5Y EPS without NRI Growth Rate : 62.17 (As of Jan. 19, 2025)

Competitive Comparison of Dizal (Jiangsu) Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Dizal (Jiangsu) Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dizal (Jiangsu) Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dizal (Jiangsu) Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Dizal (Jiangsu) Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate falls into.

Dizal (Jiangsu) Pharmaceutical Co  (SHSE:688192) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Dizal (Jiangsu) Pharmaceutical Co Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Dizal (Jiangsu) Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Dizal (Jiangsu) Pharmaceutical Co Business Description